Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: Ardea Biosciences, Inc.
Drug Studied: Lesinurad/Allopurinol Fixed-Dose Combination
Study Drug Indication: Gout
National Clinical Trial #: NCT02888054
Protocol #: RDEA594-503
Study Date: August 2016 to October 2016
Short Study Title: A study to measure and compare healthy adultsâ€™
blood levels of lesinurad and allopurinol after being
taken in a combined tablet and separate tablets,
both with food
Thank you!
As a clinical study participant, you belong to a large community of participants
around the world. You help researchers answer important health questions and
discover new medical treatments.
Thank you for taking part in the clinical study for the drugs lesinurad and
allopurinol. These drugs have been developed to treat gout, a type of arthritis.
You and all of the other participants helped researchers learn if lesinurad
and allopurinol acted the same way in the body when given with food as
1 combined tablet or 2 separate tablets.
Ardea Biosciences, Inc., the sponsor of this study, thanks you for your help
and thinks it is important for you to know the results of your study. An
independent non-profit organization called CISCRP prepared this summary
of the study results for you with the help of a medical writing organization. We
hope it helps you understand and feel proud of your important role in medical
research. If you have questions about the results, please speak with the doctor
or staff at your study site.
1